Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Iovance Biotherapeutics: Compelling Bet In Metastatic Melanoma [Seeking Alpha]

Iovance Biotherapeutics, Inc. (IOVA) 
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: iovance.com
Company Research Source: Seeking Alpha
Summary Let The Records Play It's difficult for a popular thing of the past to make a comeback, but we've seen it before (vinyl records). Perhaps, there's room for immuno-oncology, or IO?. Once the new kid on the block, IO has since taken a backseat on the biotech bus to technologies like CRISPR. Granted, much of the hype surrounding IO was unwarranted (same thing is happening with gene-editing stocks at the moment). However, this doesn't mean IO is totally dead. The following article will take a look at an up-and-coming IO player, Iovance Biotherapeutics ( IOVA ). Background Originally, Iovance entered into a 5-year CRADA (cooperative research and development agreement) with the National Cancer Institute, as well as a Patent License Agreement, (and Dr. Rosenberg) to develop adoptive cell immunotherapies that are designed to destroy metastatic melanoma cells using a patient’s own tumor infiltrating lymphocytes. Four years later, the agreement was later amend Show less Read more
Impact Snapshot
Event Time:
IOVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
IOVA alerts

from News Quantified
Opt-in for
IOVA alerts

from News Quantified